GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Sawai Pharmaceutical Co Ltd (TSE:4555) » Definitions » EPS (Basic)

Sawai Pharmaceutical Co (TSE:4555) EPS (Basic) : 円397.11 (TTM As of Mar. 2021)


View and export this data going back to 2000. Start your Free Trial

What is Sawai Pharmaceutical Co EPS (Basic)?

Sawai Pharmaceutical Co's basic earnings per share (Basic EPS) for the three months ended in Mar. 2021 was 円0.00. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Mar. 2021 was 円397.11.

Sawai Pharmaceutical Co's EPS (Diluted) for the three months ended in Mar. 2021 was 円0.00. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Mar. 2021 was 円396.69.

Sawai Pharmaceutical Co's EPS without NRI for the three months ended in Mar. 2021 was 円0.00. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Mar. 2021 was 396.69.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.


Sawai Pharmaceutical Co EPS (Basic) Historical Data

The historical data trend for Sawai Pharmaceutical Co's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sawai Pharmaceutical Co EPS (Basic) Chart

Sawai Pharmaceutical Co Annual Data
Trend Mar12 Mar13 Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21
EPS (Basic)
Get a 7-Day Free Trial Premium Member Only Premium Member Only 487.38 360.49 442.62 440.37 -

Sawai Pharmaceutical Co Quarterly Data
Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21
EPS (Basic) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 44.78 124.95 121.71 150.45 -

Sawai Pharmaceutical Co EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

Sawai Pharmaceutical Co's Basic EPS for the fiscal year that ended in Mar. 2021 is calculated as

Basic EPS (A: Mar. 2021 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(12340-0)/43.7913
=281.79

Sawai Pharmaceutical Co's Basic EPS for the quarter that ended in Mar. 2021 is calculated as

Basic EPS (Q: Mar. 2021 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(-5048-0)/43.7913
=-115.27

EPS (Basic) for the trailing twelve months (TTM) ended in Mar. 2021 adds up the quarterly data reported by the company within the most recent 12 months, which was 円397.11

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Sawai Pharmaceutical Co  (TSE:4555) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


Sawai Pharmaceutical Co EPS (Basic) Related Terms

Thank you for viewing the detailed overview of Sawai Pharmaceutical Co's EPS (Basic) provided by GuruFocus.com. Please click on the following links to see related term pages.


Sawai Pharmaceutical Co (TSE:4555) Business Description

Traded in Other Exchanges
N/A
Address
5-2-30, Miyahara, Yodogawa-Ku, Osaka, JPN, 532-0003
Sawai Pharmaceutical Co Ltd is a Japan-based pharmaceutical company. It manufactures and sells, imports, and exports pharmaceutical products. The company offers prescription drugs in various formulations, including tablets, oral dispersing tablets, capsules, granules, injections, tapes, syrups and others in the therapeutic areas of cardiovascular, gastro-intestinal, chemotherapeutics, vitamins, anti-cancer and others. The group serves various sectors such as hospitals, general practitioners, and dispensing pharmacies.

Sawai Pharmaceutical Co (TSE:4555) Headlines

No Headlines